Cyclo-oxygenase-2 in the osteolytic lesions of Langerhans cell histiocytosis.
Brown
R E
RE
D000906:Antibodies; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D015726:Giant Cells / Q000201:enzymology; D006644:Histiocytes / Q000201:enzymology; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy / Q000201:enzymology*; D006801:Humans; D007150:Immunohistochemistry; D007213:Indomethacin / Q000627:therapeutic use; D007527:Isoenzymes / Q000032:analysis*; D008565:Membrane Proteins; D010010:Osteoclasts / Q000201:enzymology; D010014:Osteolysis / Q000201:enzymology*; D010544:Peroxidases / Q000032:analysis*; D011451:Prostaglandin-Endoperoxide Synthases / Q000032:analysis*
D000906:Antibodies; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D010544:Peroxidases; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D007213:Indomethacin